Farmaceita maksas atcel\u0161ana l\u0113t\u0101kaj\u0101m z\u0101l\u0113m \u2013 kad un k\u0101?<\/p>\n
Latvijas Farmaceitisk\u0101s apr\u016bpes asoci\u0101cijas (LFAA) izpilddirektore Krist\u012bne Ju\u010dkovi\u010da skaidrojusi, ka pacientiem aptiek\u0101s vairs neb\u016bs j\u0101maks\u0101 75 centi par t\u0101 d\u0113v\u0113to recep\u0161u jeb farmaceita pakalpojumu, ta\u010du \u0161\u012bs izmai\u0146as st\u0101sies sp\u0113k\u0101 tikai no 2026. gada vidus. K\u0101 inform\u0113 port\u0101ls jauns.lv, past\u0101v ba\u017eas, ka iedz\u012bvot\u0101ji var\u0113tu sagaid\u012bt \u0161\u012bs izmai\u0146as jau no 2025. gada s\u0101kuma, ta\u010du Vesel\u012bbas ministrija (VM) ir sol\u012bjusi t\u0101s ieviest tikai n\u0101kam\u0101 gada vid\u016b. Prec\u012bz\u0101k, no 2026. gada vidus valsts apmaks\u0101s farmaceita pakalpojuma maksu vis\u0101m recep\u0161u z\u0101l\u0113m, kuru cena nep\u0101rsniedz desmit eiro. Pacientiem ar 1. grupas invalidit\u0101ti \u0161\u012b maksa tiks segta piln\u012bb\u0101.<\/p>\n
Z\u0101\u013cu cenu reformas sekas un izmai\u0146as<\/p>\n
\u0160\u0101 gada 1. janv\u0101r\u012b tika ieviests jauns z\u0101\u013cu cenu veido\u0161anas modelis, kura m\u0113r\u0137is bija nodro\u0161in\u0101t efekt\u012bv\u0101ku un ilgtsp\u0113j\u012bg\u0101ku z\u0101\u013cu cenu veido\u0161anu. \u0160\u012bs reformas rezult\u0101t\u0101 iedz\u012bvot\u0101jiem tika ieviesta 75 centu maksa par farmaceita pakalpojumu pie katras izsniegt\u0101s receptes. Lai gan s\u0101kotn\u0113ji tika prognoz\u0113ts, ka \u0161\u012b reforma samazin\u0101s medikamentu cenas, \u012bpa\u0161i d\u0101rgajiem medikamentiem (vair\u0101k nek\u0101 30 eiro), kuru cenas samazin\u0101j\u0101s par 30-50%, tie\u0161i l\u0113t\u0101ko z\u0101\u013cu segment\u0101 iedz\u012bvot\u0101ji neizjuta tik lielu cenu kritumu, cik tika cer\u0113ts. Aptieku p\u0101rst\u0101vji nor\u0101d\u012bju\u0161i, ka \u0161ie 75 centi ir b\u016btiski aptieku darb\u012bbas nodro\u0161in\u0101\u0161anai, veidojot l\u012bdz pat pusei no aptiekas m\u0113ne\u0161a ien\u0101kumiem.<\/p>\n
Farmaceita pakalpojums: kas tas ir un k\u0101p\u0113c par to maks\u0101jam?<\/p>\n
Farmaceita pakalpojums aptiek\u0101s ietver pla\u0161u darb\u012bbu kl\u0101stu, ne tikai z\u0101\u013cu izsnieg\u0161anu. Tas ietver receptes p\u0101rbaudi, iesp\u0113jamu k\u013c\u016bdu fiks\u0113\u0161anu, atbilsto\u0161u medikamentu izv\u0113li un izsnieg\u0161anu, k\u0101 ar\u012b konsult\u0113\u0161anu par z\u0101\u013cu lieto\u0161anu, mijiedarb\u012bbu un blakuspar\u0101d\u012bb\u0101m. Iepriek\u0161 \u0161is pakalpojums bija integr\u0113ts kop\u0113j\u0101 z\u0101\u013cu cen\u0101 un nebija atsevi\u0161\u0137i izdal\u012bts. Jaunais cenu veido\u0161anas modelis paredz \u0161o maksu izdal\u012bt, lai gan kop\u0113j\u0101 summa, ko maks\u0101 pacients un ko sedz valsts, ir maz\u0101ka nek\u0101 iepriek\u0161\u0113jais uzcenojums. \u0160\u012b maksa netiek piem\u0113rota b\u0113rniem l\u012bdz 18 gadu vecumam, tr\u016bc\u012bgaj\u0101m person\u0101m, patv\u0113ruma mekl\u0113t\u0101jiem un Ukrainas civiliedz\u012bvot\u0101jiem.<\/p>\n
N\u0101kotnes perspekt\u012bvas un alternat\u012bvi risin\u0101jumi<\/p>\n
Lai gan izmai\u0146as attiec\u012bb\u0101 uz farmaceita maksas atcel\u0161anu l\u0113t\u0101kaj\u0101m z\u0101l\u0113m paredz\u0113tas tikai 2026. gada vid\u016b, farmaceitu p\u0101rst\u0101vji nor\u0101d\u012bju\u0161i, ka, lai tie\u0161\u0101m j\u016btami samazin\u0101tu z\u0101\u013cu cenas, b\u016btu lietder\u012bgi apsv\u0113rt pievienot\u0101s v\u0113rt\u012bbas nodok\u013ca (PVN) samazin\u0101\u0161anu z\u0101l\u0113m. Pa\u0161laik Latvij\u0101 PVN z\u0101l\u0113m ir 12%, kas ir augst\u0101kais r\u0101d\u012bt\u0101js Baltijas valst\u012bs, sal\u012bdzinot ar Igauniju (5%) un Lietuvu (9%). Iepriek\u0161 tika ar\u012b izveidota iniciat\u012bva platform\u0101 manabalss.lv, kas pulc\u0113ja 10 000 balsis, lai atceltu pa\u0161reiz\u0113jo farmaceita pakalpojuma maksas k\u0101rt\u012bbu, nor\u0101dot, ka t\u0101 bie\u017ei vien aprobe\u017eojas ar vienk\u0101r\u0161u datora darb\u012bbu.<\/p>\n","protected":false},"excerpt":{"rendered":"Farmaceita maksas atcel\u0161ana l\u0113t\u0101kaj\u0101m z\u0101l\u0113m \u2013 kad un k\u0101? Latvijas Farmaceitisk\u0101s apr\u016bpes asoci\u0101cijas (LFAA) izpilddirektore Krist\u012bne Ju\u010dkovi\u010da skaidrojusi,…\n","protected":false},"author":2,"featured_media":87577,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[23,22273,28,29,22271,32,33,22,30,31,35,39,38,36,37,34,40,20,26,27,22274,24,25,1454,22272,21],"class_list":{"0":"post-87576","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aktualitates","8":"tag-aktualitates","9":"tag-aptiekas","10":"tag-breaking-news","11":"tag-breakingnews","12":"tag-farmaceita-pakalpojums","13":"tag-featured-news","14":"tag-featurednews","15":"tag-headlines","16":"tag-latest-news","17":"tag-latestnews","18":"tag-latvia","19":"tag-latvian","20":"tag-latviesu","21":"tag-latviesu-valoda","22":"tag-latviesuvaloda","23":"tag-latvija","24":"tag-lv","25":"tag-news","26":"tag-popularakas-zinas","27":"tag-popularakaszinas","28":"tag-recepsu-zales","29":"tag-top-stories","30":"tag-topstories","31":"tag-veselibas-ministrija","32":"tag-zalu-cenas","33":"tag-zinas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115792529582971471","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/87576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=87576"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/87576\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/87577"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=87576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=87576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=87576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}